Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Glenmark Pharma's India-US Growth Story Intact, Says Motilal Oswal, Maintaining 'Buy' — Check Target Price

    5 hours ago

    Strong growth across India and North America, a robust respiratory pipeline, and upcoming launches keep Motilal Oswal constructive on Glenmark Pharma despite a marginal cut in earnings estimates.
    Click here to Read More
    Previous Article
    Can Kansai Nerolac Paint A Better Margin Story? Macquarie Bets On Next Pricing Cycle
    Next Article
    Asian Markets Mixed As South Korea's Kosdaq Jumps 3%; Kospi, Japan's Nikkei Pare Early Gains: Here's Why

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment